Security key
746964105
Q32 Bio Inc. - Common Stock, par value $0.0001 per share (QTTB)
CUSIP: 746964105
Q4 2024 13F Holders as of 31 Dec 2024
- Type / Class
- Equity / Common Stock, par value $0.0001 per share
- Shares outstanding
- 16,820,491
- Total 13F shares
- 10,994,953
- Share change
- +389,018
- Total reported value
- $37,808,803
- Put/Call ratio
- 405%
- Price per share
- $3.44
- Number of holders
- 88
- Value change
- -$51,251,129
- Number of buys
- 50
- Number of sells
- 29
Report period
Q4 2024
Institutions
88
Top holders
10
QTTB full security history
Newer quarter: Q1 2025
Previous quarter: Q3 2024
Q32 Bio Inc. SEC filings
Q32 Bio Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 746964105
Recent filing periods:
Top shareholders of QTTB - Q32 Bio Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| PFIZER INC |
13D/G
|
Pfizer Inc. (IRS Identification No.: 13-5315170) |
2.3%
|
277,777
|
$994,442 | $0 | 31 Dec 2024 | |
| BRISTOL MYERS SQUIBB CO |
13D/G
|
— |
1.6%
|
200,244
|
$312,381 | $0 | 31 Dec 2024 | |
| ORBIMED ADVISORS LLC |
13F
3/4/5
|
Company · Director, 10%+ Owner |
13%
|
2,252,987
|
$100,528,280 | — | 30 Sep 2024 | |
| Atlas Venture Life Science Advisors, LLC |
13F
|
Company |
12%
|
2,092,106
|
$93,349,770 | — | 30 Sep 2024 | |
| Carlyle Group Inc. |
13F
|
Company |
6.6%
|
1,102,741
|
$48,619,851 | — | 30 Sep 2024 | |
| FMR LLC |
13F
|
Company |
2.5%
|
426,302
|
$19,021,595 | — | 30 Sep 2024 | |
| BlackRock, Inc. |
13F
|
Company |
2.4%
|
408,659
|
$18,234,364 | — | 30 Sep 2024 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
2.4%
|
404,411
|
$18,044,819 | — | 30 Sep 2024 | |
| ARCH Venture Management, LLC |
13F
|
Company |
1.9%
|
320,482
|
$14,299,907 | — | 30 Sep 2024 | |
| Temasek Holdings (Private) Ltd |
13F
|
Company |
1.9%
|
313,943
|
$14,008,137 | — | 30 Sep 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
1.7%
|
285,416
|
$12,735,261 | — | 30 Sep 2024 | |
| EVENTIDE ASSET MANAGEMENT, LLC |
13F
|
Company |
1.1%
|
190,000
|
$8,477,800 | — | 30 Sep 2024 | |
| HARVARD MANAGEMENT CO INC |
13F
|
Company |
0.97%
|
162,965
|
$7,271,498 | — | 30 Sep 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.78%
|
131,768
|
$5,880,777 | — | 30 Sep 2024 | |
| STATE STREET CORP |
13F
|
Company |
0.65%
|
110,164
|
$4,915,518 | — | 30 Sep 2024 | |
| Woodline Partners LP |
13F
|
Company |
0.64%
|
106,901
|
$4,769,923 | — | 30 Sep 2024 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.6%
|
100,343
|
$4,477,305 | — | 30 Sep 2024 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
0.46%
|
76,685
|
$3,421,685 | — | 30 Sep 2024 | |
| PLATINUM INVESTMENT MANAGEMENT LTD |
13F
|
Company |
0.4%
|
66,801
|
$2,980,661 | — | 30 Sep 2024 | |
| Ensign Peak Advisors, Inc |
13F
|
Company |
0.38%
|
64,481
|
$2,877,142 | — | 30 Sep 2024 | |
| ADAR1 Capital Management, LLC |
13F
|
Company |
0.38%
|
64,245
|
$2,866,612 | — | 30 Sep 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.36%
|
61,255
|
$2,733,198 | — | 30 Sep 2024 | |
| Erste Asset Management GmbH |
13F
|
Company |
0.36%
|
60,000
|
$2,677,200 | — | 30 Sep 2024 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.33%
|
55,886
|
$2,493,633 | — | 30 Sep 2024 | |
| Affinity Asset Advisors, LLC |
13F
|
Company |
0.17%
|
27,777
|
$1,239,410 | — | 30 Sep 2024 | |
| Vivo Capital, LLC |
13F
|
Company |
0.12%
|
20,559
|
$917,343 | — | 30 Sep 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0.1%
|
16,516
|
$736,944 | — | 30 Sep 2024 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.1%
|
16,437
|
$733,418 | — | 30 Sep 2024 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.1%
|
16,164
|
$721,238 | — | 30 Sep 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.09%
|
15,410
|
$687,594 | — | 30 Sep 2024 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.09%
|
15,042
|
$671,174 | — | 30 Sep 2024 | |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) |
13F
|
Company |
0.08%
|
13,229
|
$590,278 | — | 30 Sep 2024 | |
| Informed Momentum Co LLC |
13F
|
Company |
0.08%
|
12,703
|
$566,808 | — | 30 Sep 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.07%
|
12,434
|
$554,805 | — | 30 Sep 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.07%
|
11,445
|
$510,675 | — | 30 Sep 2024 | |
| BARCLAYS PLC |
13F
|
Company |
0.06%
|
10,443
|
$465,967 | — | 30 Sep 2024 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.05%
|
8,348
|
$372,480 | — | 30 Sep 2024 | |
| Trexquant Investment LP |
13F
|
Company |
0.05%
|
7,790
|
$347,590 | — | 30 Sep 2024 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
0.03%
|
4,857
|
$224,831 | — | 30 Sep 2024 | |
| Artia Global Partners LP |
13F
|
Company |
0.03%
|
4,705
|
$209,937 | — | 30 Sep 2024 | |
| CITIGROUP INC |
13F
|
Company |
0.03%
|
4,391
|
$195,926 | — | 30 Sep 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.02%
|
3,688
|
$164,559 | — | 30 Sep 2024 | |
| UBS Group AG |
13F
|
Company |
0.02%
|
3,642
|
$162,506 | — | 30 Sep 2024 | |
| MetLife Investment Management, LLC |
13F
|
Company |
0.02%
|
3,563
|
$158,981 | — | 30 Sep 2024 | |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. |
13F
|
Company |
0.02%
|
3,311
|
$147,737 | — | 30 Sep 2024 | |
| Corebridge Financial, Inc. |
13F
|
Company |
0.02%
|
3,223
|
$143,810 | — | 30 Sep 2024 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.02%
|
3,128
|
$139,571 | — | 30 Sep 2024 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.02%
|
2,779
|
$123,999 | — | 30 Sep 2024 | |
| NEW YORK STATE COMMON RETIREMENT FUND |
13F
|
Company |
0.01%
|
2,400
|
$110,976 | — | 30 Sep 2024 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0.01%
|
1,298
|
$57,917 | — | 30 Sep 2024 |
Institutional Holders of Q32 Bio Inc. - Common Stock, par value $0.0001 per share (QTTB) as of Q4 2024
As of 31 Dec 2024,
Q32 Bio Inc. - Common Stock, par value $0.0001 per share (QTTB) was held by
88 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
10,994,953 shares.
The largest 10 holders included
ORBIMED ADVISORS LLC, Atlas Venture Life Science Advisors, LLC, Carlyle Group Inc., ACORN CAPITAL ADVISORS, LLC, Sio Capital Management, LLC, Monaco Asset Management SAM, BlackRock, Inc., ARCH Venture Management, LLC, VANGUARD GROUP INC, and Temasek Holdings (Private) Ltd.
This page lists
90
institutional shareholders reporting positions in this security
for the Q4 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2024 vs Q3 2024 Across Filers
Q3 2024 holders
71
Q4 2024 holders
88
Holder diff
17
| Investor | Q3 2024 Shares | Q4 2024 Shares | Share Diff | Share Chg % | Q3 2024 Value $ | Q4 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.